The RIGHT Extension Statement for Traditional Chinese Medicine: Development, Recommendations, and Explanation.
Guidelines
RIGHT Statement
Reporting tool
Traditional Chinese Medicine
Journal
Pharmacological research
ISSN: 1096-1186
Titre abrégé: Pharmacol Res
Pays: Netherlands
ID NLM: 8907422
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
23
06
2020
revised:
05
08
2020
accepted:
24
08
2020
pubmed:
6
9
2020
medline:
14
8
2021
entrez:
5
9
2020
Statut:
ppublish
Résumé
Nowadays, the number of traditional Chinese medicine (TCM) guidelines is constantly increasing, but its reporting quality remains unsatisfactory. One of the main reasons is that there is a lack of suitable reporting standard to guide it. In response to this long-standing problem, the Reporting Items for practice Guidelines in HealThcare (RIGHT) Working Group has invited a group of TCM clinical experts, methodologists and epidemiology, and developed the RIGHT Extension Statement for TCM (RIGHT-TCM) through a multi-staged development process, including systematic review, reporting quality evaluation and online Delphi expert consensus. The RIGHT-TCM extends two sections of the RIGHT Statement, includes basic information and recommendations section. Seven strong recommendation sub-items were added to RIGHT Statement and formed the final RIGHT-TCM. The group hopes that the RIGHT-TCM may assist TCM guideline developers in reporting guidelines, support journal editors and peer reviewers when considering TCM guideline reports, and help health care practitioners understand and implement a TCM guideline. This article will introduce its background, development, recommendations and explanation.
Identifiants
pubmed: 32889127
pii: S1043-6618(20)31486-9
doi: 10.1016/j.phrs.2020.105178
pmc: PMC7462769
pii:
doi:
Types de publication
Guideline
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
105178Informations de copyright
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Références
Pharmacol Res. 2020 Jul;157:104882
pubmed: 32380051
J Proteome Res. 2019 May 3;18(5):1994-2003
pubmed: 30907085
PLoS One. 2018 Nov 16;13(11):e0207580
pubmed: 30444924
Pain. 2019 Dec;160(12):2787-2797
pubmed: 31356451
Lancet. 2000 Jan 8;355(9198):103-6
pubmed: 10675167
Am Fam Physician. 2019 Jul 15;100(2):89-96
pubmed: 31305037
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2015 Apr;35(4):411-4
pubmed: 26043561
Ann Intern Med. 2003 Sep 16;139(6):493-8
pubmed: 13679327
Chin Med. 2017 Jul 10;12:19
pubmed: 28702077
J Evid Based Med. 2018 Aug;11(3):133-135
pubmed: 30094943
BMJ. 2015 Jun 08;350:h3089
pubmed: 26055193
Ann Intern Med. 2017 Jan 17;166(2):128-132
pubmed: 27893062
Ann Transl Med. 2020 Apr;8(7):500
pubmed: 32395544
Emerg Med J. 2004 Jan;21(1):47-50
pubmed: 14734375
JAMA Netw Open. 2020 May 1;3(5):e205535
pubmed: 32459354
J Clin Epidemiol. 2017 Feb;82:47-60
pubmed: 27591906
J Clin Epidemiol. 2011 Apr;64(4):380-2
pubmed: 21185693
CMAJ. 2010 Dec 14;182(18):E839-42
pubmed: 20603348
Evid Based Complement Alternat Med. 2018 Apr 12;2018:8596918
pubmed: 29849731
BMC Complement Altern Med. 2019 Oct 22;19(1):277
pubmed: 31640688
Pharmacol Res. 2019 Apr;142:176-191
pubmed: 30818043
Eur J Neurol. 2018 Feb;25(2):275-283
pubmed: 29053896
J Ethnopharmacol. 2013 Sep 16;149(2):453-62
pubmed: 23832055
BMJ. 2008 Jul 31;337:a744
pubmed: 18669566
PLoS Med. 2010 Feb 16;7(2):e1000217
pubmed: 20169112
BMJ. 2018 Feb 5;360:j5158
pubmed: 29437564
BMJ. 2004 Oct 16;329(7471):868-9
pubmed: 15485939
Ann Intern Med. 2017 Jul 18;167(2):W7-W20
pubmed: 28654988
Ann Intern Med. 1993 May 1;118(9):731-7
pubmed: 8460861
Eur J Cancer Care (Engl). 2018 Mar;27(2):e12802
pubmed: 29323766
Evid Based Complement Alternat Med. 2015;2015:761565
pubmed: 25815040
Health Qual Life Outcomes. 2020 May 7;18(1):125
pubmed: 32380997
Joint Bone Spine. 2017 Dec;84(6):657-661
pubmed: 28219657
Stat Med. 2012 Mar 30;31(7):602-5
pubmed: 22238066
Nutrition. 2010 Jan;26(1):33-9
pubmed: 20005465